Pharmaceutical launches remain one of the toughest challenges in our industry. Despite years of R&D and investment, nearly half of new products still fail to meet commercial expectations, and those that stumble early rarely recover.

Tivmek was founded to tackle this problem by offering a unique blend of strategic insight, deep therapeutic expertise, unparalleled KOL connectivity, and hands-on execution—empowering companies with late-stage assets to navigate complex pre-launch pathways with confidence and precision. Whether our partners aim to independently launch their products in Canada or pursue out-licensing opportunities, Tivmek provides agile, cost-effective solutions to support every step of the journey. We believe that early action sets the stage for strong market entry.